BIO89-100-122 - A Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy, Safety and Tolerability of BIO89-100 in Subjects with Biopsy-Confirmed Nonalcoholic Steatohepatitis (NASH)
Clinical Trial Grant
Administered By
Radiology, Abdominal Imaging
Awarded By
M3 Wake Research Inc
Start Date
September 17, 2021
End Date
December 16, 2022
Administered By
Radiology, Abdominal Imaging
Awarded By
M3 Wake Research Inc
Start Date
September 17, 2021
End Date
December 16, 2022